In addition, the accumulation of HF647-Lac-β-CyD was inhibited in the presence of AF, which is a competitive inhibitor of ASGPR, suggesting that Lac-β-CyD might accumulate in liver tissue through its interaction with ASGPR. The gene discussed is ASGR1; the disease is atrial fibrillation.